Literature DB >> 1826437

Risk of invasive cancer in women with lobular carcinoma in situ of the breast.

B Salvadori1, C Bartoli, S Zurrida, V Delledonne, P Squicciarini, D Rovini, L Barletta.   

Abstract

100 women underwent wide resection for palpable or mammographically detected breast lesions (1 woman had bilateral lesions). Histology excluded invasive cancer, but one or more foci of lobular carcinoma in situ (LCIS) were observed. There have been no recurrences in the 20 women who underwent total mastectomy. In the 12 patients who had a subsequent wide excision and the 68 who received no other treatment 5 presented with an invasive cancer in the same breast at some distance from the LCIS site (median follow-up 58 months). The (observed/expected) rate per 1000 per year is 10.3 for an untreated LCIS. LCIS is therefore a risk factor for invasive carcinoma. Nevertheless this risk does not indicate the use of mutilating procedures and a wait-and-see policy is appropriate.

Entities:  

Mesh:

Year:  1991        PMID: 1826437     DOI: 10.1016/0277-5379(91)90055-i

Source DB:  PubMed          Journal:  Eur J Cancer        ISSN: 0959-8049            Impact factor:   9.162


  7 in total

Review 1.  Current management of lesions associated with an increased risk of breast cancer.

Authors:  Monica Morrow; Stuart J Schnitt; Larry Norton
Journal:  Nat Rev Clin Oncol       Date:  2015-01-27       Impact factor: 66.675

2.  Interpretation of the risk associated with the unexpected finding of lobular carcinoma in situ.

Authors:  S Zurrida; C Bartoli; V Galimberti; R Raselli; L Barletta
Journal:  Ann Surg Oncol       Date:  1996-01       Impact factor: 5.344

Review 3.  The morphologic spectrum of lobular carcinoma in situ (LCIS) observations on clinical significance, management implications and diagnostic pitfalls of classic, florid and pleomorphic LCIS.

Authors:  Edi Brogi
Journal:  Virchows Arch       Date:  2022-05-14       Impact factor: 4.064

Review 4.  Management of in situ and minimally invasive breast carcinoma.

Authors:  E R Frykberg; K I Bland
Journal:  World J Surg       Date:  1994 Jan-Feb       Impact factor: 3.352

5.  Lobular carcinoma in situ: observation without surgery as an appropriate therapy.

Authors:  W Carson; E Sanchez-Forgach; P Stomper; R Penetrante; T N Tsangaris; S B Edge
Journal:  Ann Surg Oncol       Date:  1994-03       Impact factor: 5.344

6.  Lobular carcinoma in situ (LCIS) of the breast: is long-term outcome similar to ductal carcinoma in situ (DCIS)? Analysis of 200 cases.

Authors:  Bruno Cutuli; Brigitte De Lafontan; Youlia Kirova; Hugues Auvray; Agnes Tallet; Sandrine Avigdor; Claire Brunaud; Catherine Delva
Journal:  Radiat Oncol       Date:  2015-05-06       Impact factor: 3.481

7.  Impact of preventive therapy on the risk of breast cancer among women with benign breast disease.

Authors:  Jack Cuzick; Ivana Sestak; Mangesh A Thorat
Journal:  Breast       Date:  2015-11       Impact factor: 4.380

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.